CN112107656A - Anticancer Chinese medicinal preparation and its preparation method - Google Patents

Anticancer Chinese medicinal preparation and its preparation method Download PDF

Info

Publication number
CN112107656A
CN112107656A CN201910532883.3A CN201910532883A CN112107656A CN 112107656 A CN112107656 A CN 112107656A CN 201910532883 A CN201910532883 A CN 201910532883A CN 112107656 A CN112107656 A CN 112107656A
Authority
CN
China
Prior art keywords
chinese medicinal
herb
preparation
medicinal preparation
anticancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201910532883.3A
Other languages
Chinese (zh)
Inventor
徐建国
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201910532883.3A priority Critical patent/CN112107656A/en
Publication of CN112107656A publication Critical patent/CN112107656A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/07—Basidiomycota, e.g. Cryptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/233—Bupleurum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/282—Artemisia, e.g. wormwood or sagebrush
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/288—Taraxacum (dandelion)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/51—Gentianaceae (Gentian family)
    • A61K36/515—Gentiana
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/539—Scutellaria (skullcap)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
    • A61K36/708—Rheum (rhubarb)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/74—Rubiaceae (Madder family)
    • A61K36/748—Oldenlandia or Hedyotis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/78—Saururaceae (Lizard's-tail family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Abstract

The invention discloses an anticancer Chinese medicinal preparation and a preparation method thereof, wherein the anticancer Chinese medicinal preparation is prepared from the following raw materials in parts by weight: 15 g of linearstripe rabdosia herb, 15 g of oriental wormwood, 15 g of penthorum chinense pursh, 15 g of gentian, 15 g of radix bupleuri, 15 g of cogongrass rhizome, 20 g of barbed skullcap herb, 20 g of spreading hedyotis herb, 15 g of sticktight, 15 g of discolor cinquefoil herb, 15 g of ochronotus fulva, 15 g of heartleaf houttuynia herb, 15 g of garden balsam seed, 15 g of aralia elata, 15 g of sun euphorbia herb, 15 g of dandelion, 15 g of centella asiatica and 5 g of rhubarb. The invention relates to a pure natural traditional Chinese medicine preparation, which is mainly used for liver cancer patients with hepatitis A, hepatitis B and hepatitis B, alcoholic liver, cirrhosis caused by fatty liver and hepatic ascites. The pain symptom of the patients is greatly relieved through the clinical administration of a plurality of patients, the living quality is improved, and the rehabilitation purpose is achieved.

Description

Anticancer Chinese medicinal preparation and its preparation method
Technical Field
The invention relates to the technical field of anticancer preparation, in particular to an anticancer traditional Chinese medicine preparation and a preparation method thereof.
Background
Cancer is one of the most serious diseases endangering human health and is called absolute disease. Cancer is a life style disease, the cause of the disease is mostly internal and external mixed evil, and the gene mutation is caused by the combined action of the bad stimulation of external society, environment, psychology and other aspects on the basis of the disorder of human constitution, emotion, diet, life and other aspects, so as to cause the result of abnormal cell division. From the theory of syndrome differentiation of traditional Chinese medicine, the traditional Chinese medicine is formed by coagulation and cementation of various deficiency syndromes, qi stagnation, blood stasis, phlegm coagulation, heat toxin and other pathogens caused by the deficiency of vital qi of human bodies, is caused by unsmooth circulation of qi and blood of human bodies, is a local manifestation of systemic diseases, and can show different syndromes in different stages of different disease stages. The traditional Chinese medicine is used for treating cancer, and has the principles of clearing heat and removing toxicity, activating blood and dissolving stasis, dredging channels and collaterals, eliminating dampness and breaking hard mass, reinforcing primordial qi and consolidating the foundation and the like.
At present, the treatment methods of cancer mainly comprise operations, chemotherapy and radiotherapy in western medicine, and the methods play a positive role in the treatment of the cancer. However, extensive aggressive treatments such as radical enlargement, high dose chemotherapy and radiotherapy in surgery do not only serve to prolong the life of the patient, but also reduce the quality of life of the patient, aggravate the symptoms of the patient, such as digestive tract reactions (poor appetite, nausea, vomiting), bone marrow suppression (leukopenia, anemia), impaired organ function, and the like, and cause most patients to fail to adhere to and complete the treatment, and finally fail the treatment. The western medicine for cancer is provided with a plurality of medicines, but most of the medicines can only relieve symptoms, and the side effect is large. The problem of the liver cirrhosis precancerous lesion is that the clinical hot is the problem, and the treatment method for inhibiting the precancerous lesion by combining multiple disciplines is discussed, so that the curative effect can be greatly improved. The traditional Chinese medicine has the effects of improving the immunity of the organism and resisting cancer, the treatment is mainly based on the treatment methods of soothing the liver, promoting blood circulation, removing dampness by diuresis, detoxifying and removing food retention and the like at the early stage of liver cancer, the method is mainly based on strengthening the body resistance and consolidating the constitution at the middle and later stages, the method is mainly based on strengthening the spleen and replenishing qi, nourishing blood and softening the liver and nourishing yin and tonifying the kidney, the syndrome differentiation treatment embodies the individual treatment characteristics of the traditional Chinese medicine, and the traditional Chinese medicine has better curative effect on cause and syndrome. In addition, the traditional Chinese medicine is combined with chemotherapy, the respective advantages of the traditional Chinese medicine and the western medicine are brought into play, the adverse reaction of chemotherapy can be effectively prevented or alleviated, the patients can be ensured to successfully finish the chemotherapy treatment, the sensitivity of tumor cells to chemotherapy medicines can be increased, the tolerance of organisms to the chemotherapy is improved, the life quality is improved, the life cycle is prolonged, and the like.
In recent years, in China, people find that the cancer prevention and anticancer effect of the traditional Chinese medicine is better than that of a treatment method of western medicine, the pain of patients can be relieved, and the life quality of the patients can be improved.
Disclosure of Invention
Aiming at the defects of the prior art, the invention provides an anticancer traditional Chinese medicine preparation and a preparation method thereof, wherein the anticancer traditional Chinese medicine preparation is prepared from the following raw materials in parts by weight: 15 g of linearstripe rabdosia herb, 15 g of oriental wormwood, 15 g of penthorum chinense pursh, 15 g of gentian, 15 g of radix bupleuri, 15 g of cogongrass rhizome, 20 g of barbed skullcap herb, 20 g of spreading hedyotis herb, 15 g of sticktight, 15 g of discolor cinquefoil herb, 15 g of ochronotus fulva, 15 g of heartleaf houttuynia herb, 15 g of garden balsam seed, 15 g of aralia elata, 15 g of sun euphorbia herb, 15 g of dandelion, 15 g of centella asiatica and 5 g of rhubarb.
Preferably, the traditional Chinese medicine raw materials are soaked in mineral water with the volume 2-4 times of that of the traditional Chinese medicine raw materials for 2-3 hours.
Preferably, the traditional Chinese medicine raw materials except the rhubarb are boiled by strong fire after being soaked by mineral water, decocted by slow fire, and dregs are removed after the decoction to obtain juice; filtering, mixing filtrates, standing, collecting supernatant, concentrating into soft extract, drying under reduced pressure, and pulverizing into fine powder; pulverizing radix et rhizoma Rhei into fine powder; mixing the above dry extract powder and radix et rhizoma Rhei powder, granulating with ethanol, drying, and packaging.
Preferably, the decoction is carried out in a way that the mass volume ratio of the first decoction dregs to water is 1: 6-12 in g/mL.
Preferably, the method is suitable for patients with liver cancer and liver cirrhosis, and the hepatogenic causes include chronic hepatitis A and hepatitis C virus (HCG) for resisting liver cancer and liver cirrhosis, and the administration is carried out 1 time respectively in the morning and at night.
Compared with the prior art, the invention has the beneficial effects that: the obtained anticancer Chinese medicine can improve immunity, inhibit the growth and diffusion of cancer cells, prevent cancer formation, treat various cancers, relieve and eliminate side effects caused by radiotherapy or chemotherapy, strengthen body constitution, and improve life quality of patients.
The main component of the invention is oldenlandia diffusa which is a yearly-raw and shavings herb, and the patent medicine is bitter and light in taste and cold in nature. Has the main effects of clearing away heat and toxic materials, relieving pain and dissipating stagnation, promoting blood circulation, inducing diuresis and removing dampness, and is especially good at treating various types of inflammation. In clinical practice, the compatibility of oldenlandia diffusa is found to be proper, which can cure various diseases.
The main component of the invention is the barbed skullcap herb which has the functions of clearing away heat and toxic material, promoting blood circulation by removing blood stasis and promoting urination. Belongs to heat-clearing and toxicity-removing herbs in the category of heat-clearing herbs. Has anticancer effect and has mild inhibition effect on blood cells of acute myelocytic leukemia (NvIL). Improving the function of an immune system, but inhibiting the thymus index of the mice by large-dose injection; has antibacterial effect; has strong effect of resisting smooth muscle contraction caused by histamine. Has good spasmolytic and phlegm eliminating effects. Has diuretic, respiratory stimulating, and snake venom expelling effects.
The invention relates to a pure natural traditional Chinese medicine preparation, which is mainly used for liver cancer patients with hepatitis A, hepatitis B and hepatitis B, alcoholic liver, cirrhosis caused by fatty liver and hepatic ascites. The pain symptom of the patients is greatly relieved through the clinical administration of a plurality of patients, the living quality is improved, and the rehabilitation purpose is achieved.
Detailed Description
The technical solutions in the embodiments of the present invention will be clearly and completely described below with reference to the embodiments of the present invention, and it is obvious that the described embodiments are only a part of the embodiments of the present invention, and not all of the embodiments. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
An anticancer Chinese medicinal preparation and its preparation method, is prepared from the following raw materials in parts by weight: 15 g of linearstripe rabdosia herb, 15 g of oriental wormwood, 15 g of penthorum chinense pursh, 15 g of gentian, 15 g of radix bupleuri, 15 g of cogongrass rhizome, 20 g of barbed skullcap herb, 20 g of spreading hedyotis herb, 15 g of sticktight, 15 g of discolor cinquefoil herb, 15 g of ochronotus fulva, 15 g of heartleaf houttuynia herb, 15 g of garden balsam seed, 15 g of aralia elata, 15 g of sun euphorbia herb, 15 g of dandelion, 15 g of centella asiatica and 5 g of rhubarb.
In the invention, the traditional Chinese medicine raw materials are soaked in mineral water with 2-4 times of volume for 2-3 hours.
In the invention, the traditional Chinese medicine raw materials except rhubarb are boiled with strong fire after being soaked in mineral water, and then decocted with slow fire, and dregs are removed after decoction to obtain juice; filtering, mixing filtrates, standing, collecting supernatant, concentrating into soft extract, drying under reduced pressure, and pulverizing into fine powder; pulverizing radix et rhizoma Rhei into fine powder; mixing the above dry extract powder and radix et rhizoma Rhei powder, granulating with ethanol, drying, and packaging.
In the invention, the decoction is specifically that the mass-volume ratio of the first decoction dregs to water is 1: 6-12 in g/mL.
The method is suitable for patients with liver cancer and liver cirrhosis, and the hepatogenic causes include chronic hepatitis A and hepatitis C virus (HCH) for resisting liver cancer and liver cirrhosis, and is taken 1 time in the morning and at night. The invention relates to a pure natural traditional Chinese medicine preparation, which is mainly used for liver cancer patients with hepatitis A, hepatitis B and hepatitis B, alcoholic liver, cirrhosis caused by fatty liver and hepatic ascites. The pain symptom of the patients is greatly relieved through the clinical administration of a plurality of patients, the living quality is improved, and the rehabilitation purpose is achieved.
The invention has the advantages that the invention totally adopts natural medicines, overcomes the toxic and side effects of synthetic medicines, carries out dialectical treatment according to the principle of strengthening body resistance and eliminating evil in traditional Chinese medicine, obviously improves the curative effect, has the total effective rate of 74 percent according to the observation of the curative effect of 50 patients, wherein 14 cases of significant effect (basic cure) account for 28 percent, and 23 cases of effective effect account for 46 percent, and is convenient to take and carry. It also has prophylactic and health promoting effects.
Also, the terms "comprises," "comprising," or any other variation thereof, are intended to cover a non-exclusive inclusion, such that a process, method, article, or apparatus that comprises a list of elements does not include only those elements but may include other elements not expressly listed or inherent to such process, method, article, or apparatus.
The present invention is not limited to the above preferred embodiments, and any modifications, equivalent substitutions, improvements, etc. within the spirit and principle of the present invention should be included in the protection scope of the present invention.

Claims (5)

1. An anticancer Chinese medicinal preparation and a preparation method thereof, which are characterized in that: the feed is prepared from the following raw materials in parts by weight: 15 g of linearstripe rabdosia herb, 15 g of oriental wormwood, 15 g of penthorum chinense pursh, 15 g of gentian, 15 g of radix bupleuri, 15 g of cogongrass rhizome, 20 g of barbed skullcap herb, 20 g of spreading hedyotis herb, 15 g of sticktight, 15 g of discolor cinquefoil herb, 15 g of ochronotus fulva, 15 g of heartleaf houttuynia herb, 15 g of garden balsam seed, 15 g of aralia elata, 15 g of sun euphorbia herb, 15 g of dandelion, 15 g of centella asiatica and 5 g of rhubarb.
2. The anticancer Chinese medicinal preparation and the preparation method thereof according to claim 1, wherein the anticancer Chinese medicinal preparation comprises the following raw materials: soaking the above Chinese medicinal materials in 2-4 times of mineral water for 2-3 hr.
3. The anticancer Chinese medicinal preparation and the preparation method thereof according to claim 1, wherein the anticancer Chinese medicinal preparation comprises the following raw materials: boiling the above Chinese medicinal materials except radix et rhizoma Rhei in mineral water, decocting with slow fire, and removing residue to obtain decoction; filtering, mixing filtrates, standing, collecting supernatant, concentrating into soft extract, drying under reduced pressure, and pulverizing into fine powder; pulverizing radix et rhizoma Rhei into fine powder; mixing the above dry extract powder and radix et rhizoma Rhei powder, granulating with ethanol, drying, and packaging.
4. The anticancer Chinese medicinal preparation and the preparation method thereof according to claim 1, wherein the anticancer Chinese medicinal preparation comprises the following raw materials: the specific decocting method is that the mass volume ratio of the first decoction dregs to water is 1: 6-12 in g/mL.
5. The anticancer Chinese medicinal preparation and the preparation method thereof according to claim 1, wherein the anticancer Chinese medicinal preparation comprises the following raw materials: the method is suitable for patients with liver cancer and liver cirrhosis, and the hepatogenic causes include chronic hepatitis A and hepatitis C virus (HCH) for resisting liver cancer and liver cirrhosis, and is taken 1 time in the morning and at night.
CN201910532883.3A 2019-06-19 2019-06-19 Anticancer Chinese medicinal preparation and its preparation method Pending CN112107656A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201910532883.3A CN112107656A (en) 2019-06-19 2019-06-19 Anticancer Chinese medicinal preparation and its preparation method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201910532883.3A CN112107656A (en) 2019-06-19 2019-06-19 Anticancer Chinese medicinal preparation and its preparation method

Publications (1)

Publication Number Publication Date
CN112107656A true CN112107656A (en) 2020-12-22

Family

ID=73795709

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201910532883.3A Pending CN112107656A (en) 2019-06-19 2019-06-19 Anticancer Chinese medicinal preparation and its preparation method

Country Status (1)

Country Link
CN (1) CN112107656A (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1097621A (en) * 1994-06-06 1995-01-25 郭文峰 Anti-cancer powder

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1097621A (en) * 1994-06-06 1995-01-25 郭文峰 Anti-cancer powder

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
隋鑫等: "中医防治原发性肝癌", 《实用中医内科杂志》 *

Similar Documents

Publication Publication Date Title
CN103860699A (en) Pharmaceutical composition for radically treating hypertension, hyperlipidemia and hyperglycemia
CN101062368A (en) Chinese traditional medicine for treating cirrhosis ascites
CN102512632B (en) Chinese herbal composition for treating abnormal menstruation
CN1436564A (en) Liver cancer treating medicine and its prepn
CN102247497A (en) Chinese patent medicine for treating rheumatoid arthritis
CN104740583B (en) It is a kind of to be used to alleviate Chinese medicine preparation of Crohn disease and preparation method thereof
CN101518640A (en) Chinese traditional medicine prescription for treating tumor
CN1507884A (en) Chinese medicine powder and decoction composition for treating cancers
CN102631538B (en) Traditional Chinese medicine for treating heart disease
CN105943705A (en) Traditional Chinese medicine composition for treating rheumatoid arthritis and preparation method thereof
CN1052889C (en) Chinese proprietary for curing hepatitis
CN102028831B (en) Traditional Chinese medicine composition for treating tumors or cancers and preparation method thereof
CN101204494B (en) Medicine for chronic enteritis
CN1152453A (en) Medicine for curing chest rheumatism and pain and preparation method
CN1101199C (en) Chinese-medicinal capsule for treating hyperlipomia
CN112107656A (en) Anticancer Chinese medicinal preparation and its preparation method
CN105944031A (en) Anti-radiation traditional Chinese medicine and preparation method
CN1192922A (en) Preparatory Chinese-medicine for treatment of hepatitis and hepatoascites
CN102078531A (en) Medicine for treating hypertension and preparation method thereof
CN105232677A (en) Traditional Chinese medicine composition for treating myocardial infarction and preparation method of traditional Chinese medicine composition
CN112494614A (en) Chinese medicinal formula for preventing and treating cancer by using combination of pawpaw and various medicines
CN101485823B (en) Medicament for treating lung cancer and preparation method thereof
CN104623532A (en) Traditional Chinese medicine composition for treating glioma and preparation method thereof
CN104840891A (en) Traditional Chinese medicine preparation used for treating alcoholic cardiomyopathy and preparation method thereof
CN102430018A (en) Medicinal composition for treating rheumatic and rheumatoid arthritis

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20201222

RJ01 Rejection of invention patent application after publication